Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment; Copyright 1201 exemption impacting medical devices
American Rescue Plan Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · fourth_quarter · Q4
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment; Copyright 1201 exemption impacting medical devices
Source: Senate LDA
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
American Rescue Plan Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
American Rescue Plan Act of 2021, HR 1319: Funding for testing, and other covid-19 policies; Covid-19 Testing: Policies associated with use of serology and antigen testing; Verifying Accurate Leading-Edge IVCT Development Act (VALID), S. 2209 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes), HR 4128 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes); Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
American Rescue Plan Act of 2021, HR 1319: Funding for testing, and other covid-19 policies; Covid-19 Testing: Policies associated with use of serology and antigen testing; Verifying Accurate Leading-Edge IVCT Development Act (VALID), S. 2209 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes), HR 4128 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes); Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment; Copyright 1201 exemption impacting medical devices
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
Black Lung Benefits Improvement Act of 2022
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
Black Lung Benefits Improvement Act of 2022
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
American Rescue Plan Act of 2021, HR 1319: Funding for testing, and other covid-19 policies; Covid-19 Testing: Policies associated with use of serology and antigen testing; Verifying Accurate Leading-Edge IVCT Development Act (VALID), S. 2209 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes), HR 4128 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes); Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
VALID Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment; Copyright 1201 exemption impacting medical devices
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
Removing Barriers to Allergy Diagnostic Testing Act of 2019
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
Allergy Testing Access Act of 2019
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
Allergy Testing Access Act of 2019
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
Export of raw materials to China.
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · third_quarter · Q3
Export of raw materials to China.
HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).
National Interest Exemptions.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, U.S. Customs & Border Protection
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · second_quarter · Q2
National Interest Exemptions.
Export of raw materials to China.
American Rescue Plan Act of 2021, HR 1319: Funding for testing, and other covid-19 policies; Covid-19 Testing: Policies associated with use of serology and antigen testing; Verifying Accurate Leading-Edge IVCT Development Act (VALID), S. 2209 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes), HR 4128 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes); Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
Legislation to appropriately pay for PET diagnostic drugs.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, U.S. Customs & Border Protection
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · first_quarter · 1A
- American Rescue Plan - funding for expanding COVID-19 testing, lab and hospital infrastructure, surveillance
- Cybersecurity requirements for critical infrastructure. - Legacy imaging equipment and cybersecurity - National Interest Waiver program for essential workers entering the U.S. - US Department of Homeland Security
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
- Government Procurement Agreement, Buy America - Exports of human sourced and animal sourced material to China - US Department of Agriculture, Animal Plant and Health Inspection Service (APHIS), the US Department of Commerce, the US Food and Drug Administration - Presidents Executive Order on Supply Chain and Rare Earth
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · first_quarter · Q1
- Government Procurement Agreement, Buy America - Exports of human sourced and animal sourced material to China - US Department of Agriculture, Animal Plant and Health Inspection Service (APHIS), the US Department of Commerce, the US Food and Drug Administration - Presidents Executive Order on Supply Chain and Rare Earth
- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees
- American Rescue Plan - funding for expanding COVID-19 testing, lab and hospital infrastructure, surveillance
- Cybersecurity requirements for critical infrastructure. - Legacy imaging equipment and cybersecurity - National Interest Waiver program for essential workers entering the U.S. - US Department of Homeland Security
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2021 · first_quarter · RR
Healthcare, medical device manufacturing, service and sales, and taxes and trade
Healthcare, medical device manufacturing, service and sales, and taxes and trade
Healthcare, medical device manufacturing, service and sales, and taxes and trade